- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Physicians Call for ONC to Change EHR Certification Process
An American Medical Association-led coalition of 35 medical societies has urged the Office of the National Coordinator for Health Information Technology to reevaluate the current electronic health record certification process.
An American Medical Association-led coalition of 35 medical societies, stressing "elevated concern" about the certification of electronic health record (EHR) systems, has sent a letter to National Coordinator Karen B. DeSalvo, MD, MPH, MSc, urging the Office of the National Coordinator for Health Information Technology to reevaluate its "current trajectory" and recommending changes to the certification process.
The letter identifies a myriad of problems with the current EHR certification process, including: the lack of necessary security measures to protect patient information; the lack of oversight on the authorized testing and certification bodies; concern that test methods are no guarantee that the systems will perform as expected in production; and fear that the administration is "pushing too quickly" for use of certified EHRs beyond the Meaningful Use program.
Read more: http://bit.ly/1yKxwNg
Source: Fierce EMR
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
